Nasal Spray Product Range – The demand for nasal sprays in India is growing rapidly and this is due to several factors like nasal allergies and respiratory disorders. According to market research, the Indian nasal spray market is expected to grow at a CAGR of 14.2% from 2022 to 2028. The report also states that the market is expected to reach a value of INR 1,650.7 crores by 2028. Furthermore, awareness about nasal sprays and their benefits has been increasing among the general population in recent years.
Scott Morrison offers a focused Respiratory and Nasal Care range of 16 products for PCD Pharma Franchise partners across India. The range includes oral bronchodilator and mucolytic products, intranasal sprays, and inhalation capsules in dual and triple combinations, all offered under a monopoly-rights franchise model. Whether you are a new entrant or an experienced distributor, this range gives you a specialist portfolio that doctors recognise and prescribe.
India is home to different respiratory diseases such as allergic rhinitis, sinusitis, and nasal congestion, which contribute to the demand for nasal sprays. Additionally, pollution levels, environmental factors, and changing weather conditions can exacerbate respiratory symptoms and increase the need for nasal sprays. Many people are seeking relief from nasal congestion and related symptoms, leading to an increased demand for nasal sprays.
To fulfil this demand, Scott Morrison offers the best quality nasal spray product range in India. To start a nasal spray franchise in India or for more details, you can contact us at +91-6280000921 or email us at info.scottmorrison@gmail.com.
India has about 18% of the world’s population still a Global Burden of Disease analysis published in The Lancet Global Health noticed that 32% of the global health loss from incurable respiratory diseases in 2016 occurred in India. The same study projected about 55.3 million COPD cases and 37.9 million asthma cases in the country. The reports explained COPD as the second leading individual cause of disease burden in India.
Various everyday factors keep the demand consistently high:
A lot of patients with incurable conditions require regular and long term treatment that creates consistent repeat prescriptions for brands that doctors know and rely on.
Respiratory medicines combine high prescription volumes with specialist-led prescribing. Chest physicians, pulmonologists, ENT specialists, allergists and general physicians all regularly prescribe from this segment. Nasal sprays serve patients with allergic rhinitis and related nasal problems, while inhalation therapies serve patients on long-term asthma and COPD management.
For a franchise partner, this means:
Many medications are given in the nose with a nasal spray. Most of these medications treat problems within the nose and sinus area, such as nasal congestion, cold, a runny nose and many other diseases too. Nasal sprays are available as over-the-counter drugs. The nasal spray comes in two forms: a regular spray and a pump spray. It’s important to know the use of these products correctly. This makes sure they deliver the medication properly so your body can absorb it.
Moreover, the nasal spray provides effective medication as the body consumes the drug completely.
To start using the nasal spray, you need to close the other nostril that isn’t sucking the medication. Just give a gentle push on that free side of the nose.
Now, push the spray bottle tip into the nostril through which you want to consume the medicine.
Hereafter, you will breathe in deeply through that single nostril.
Now, remove the bottle tip from the nostril and sniff once or twice.
You can repeat the same process if prescribed. At least a 10-second wait is a must between each process.
You can repeat the process 1 to 4 times on the other nostril.
Respiratory and nasal products work best when they are used exactly as prescribed. Corticosteroid, bronchodilator and combination products are prescription medicines, and doctors choose the product, strength and duration based on each patient’s condition. A few points are worth sharing with customers:
Are you ready to make your first step towards the nasal spray business? The only worrying point for you might be the selection of a perfect partner for the venture. If same is the case, here’s the solution for you.
Scott Morrison is there to back you. You can approach the company for best Nasal spray pcd franchise in India. You just need to order the firm as per your requirements in your area. Scott Morrison promises to deliver high-quality nasal spray products at the best prices in the market.
Here’s why you should shake hands with Scott Morrison for the nasal spray PCD franchise:
A: Nasal Sprays are primarily used to provide relief and treat symptoms of nasal congestion such as allergies, sinusitis, and other respiratory conditions. These nasal sprays work by reducing inflammation, blocking allergic reactions, and constricting blood vessels in the nasal passages to relieve congestion.
A: Yes, nasal sprays are safe to use if you are using them as per the directions by your doctor. It is very important to follow all the instructions and directions that are given by the doctor and the healthcare professionals, especially in conditions when you are pregnant and breastfeeding.
A: It all depends upon the specific condition and the type of nasal spray. The common side effects may include temporary irritation like a burning sensation, sneezing, dryness, and mild nosebleeds. That nasal spray that contains steroids may lead to severe side effects. So it is important to consult with the doctor and healthcare professional.
A: Adults—at first, 2 sprays in each nostril once a day. Some patients may need 1 spray in each nostril 2 times a day (morning and evening). Your doctor may adjust your dose as needed. Children 4 years of age and older—at first, 1 spray in each nostril once a day.
Dual therapy combines two medicines, such as a bronchodilator and an inhaled corticosteroid. Triple therapy adds a third medicine, usually a second type of bronchodilator. The doctor decides which one a patient needs.
Maintenance inhalers such as combination capsules are meant for regular, long-term control. They are not designed for sudden attacks, and a patient should follow the emergency plan given by the doctor.
India carries a heavy burden of asthma, COPD and allergic conditions, and these medicines are prescribed by specialists. This supports steady, repeat demand for partners who build trust with doctors.
Yes. Scott Morrison offers monopoly-rights PCD franchise opportunities. Your territory is confirmed in the franchise agreement, so please discuss your preferred area with our team.
You generally need a valid wholesale drug license and GST registration. Rules can vary by state, so check with your local drug control authority and speak to our team for guidance.
Our products are manufactured in a GMP-certified facility following WHO-GMP and DCGI guidelines, and Scott Morrison is an ISO-certified company. Partners can request relevant documents from our team.